Search alternatives:
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
significant source » significant burden (Expand Search), significant cause (Expand Search)
spatial decrease » spatial release (Expand Search), small decrease (Expand Search)
Showing 581 - 600 results of 10,706 for search '(( significant ((spatial decrease) OR (substantial decrease)) ) OR ( significant source decrease ))', query time: 0.63s Refine Results
  1. 581
    Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis).

    Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 582
    Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis).

    Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 583
    Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (pmol/L) outcomes at baseline and 25 weeks (mITT analysis).

    Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (pmol/L) outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 584
    Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (nmol/L), outcomes at baseline and 25 weeks (mITT analysis).

    Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (nmol/L), outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 585
    SLE T cells display more genes with increased rather than decreased expression.

    SLE T cells display more genes with increased rather than decreased expression. by Sean J. Bradley (823158)

    Published 2015
    Save to List
    Saved in:
  6. 586
    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe

    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 587
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 588
    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe

    Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 589
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 590
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 591
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 592
    DDC for four anticoagulants from 2019 to 2023.

    DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 593
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 594
    The expenditure on anticoagulants in the period of 2019-2023(million CNY).

    The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 595
    Heavy metals concentration in ammonia removal rate; as % of the source (ARRS) and ammonia removal rate; as % of the control (ARRC) of different treatments (Means± SE).

    Heavy metals concentration in ammonia removal rate; as % of the source (ARRS) and ammonia removal rate; as % of the control (ARRC) of different treatments (Means± SE). by Ghada R. Sallam (18319994)

    Published 2024
    Save to List
    Saved in:
  16. 596
    Age, sex, study duration, experience with radiography, traumatology, radiology.

    Age, sex, study duration, experience with radiography, traumatology, radiology. by Eszter Nagy (398278)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 597
    S1 Data -

    S1 Data - by Eszter Nagy (398278)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 598
    Different cases of erroneously annotated fractures in pediatric wrist radiographs.

    Different cases of erroneously annotated fractures in pediatric wrist radiographs. by Eszter Nagy (398278)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 599
    Inverse exponential curves fitted within the regression analyses of the main parameters of interest.

    Inverse exponential curves fitted within the regression analyses of the main parameters of interest. by Eszter Nagy (398278)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 600
    Fig 2 -

    Fig 2 - by Eszter Nagy (398278)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: